ISB News

Reimagine: Your Immune System Event Generates $60,000 to Fuel Critical ISB Research

More than 300 people registered for Reimagine: Your Immune System, ISB’s annual virtual fundraiser, for an evening that included guest appearances by giants in immunology.

The main event of the evening was a robust conversation between ISB President Dr. Jim Heath, Nobel laureate Dr. David Baltimore, and immunology expert Mark Davis, who Heath said “is well known for basically discovering most things about T cells.” Of the conversation, Heath said it was “about as much immunology and virology expertise as one can imagine.” The three scientists talked about how science has changed over the past two years of the COVID-19 pandemic, the challenges of understanding the complexities of the immune system, and much more. 

The one-hour Reimagine event also included guest appearances by ISB researchers, including a short primer of what the immune system is by ISB Assistant Professor Dr. Jenn Hadlock, and a video montage of several of our scientists – Associate Professor Dr. Naeha Subramanian, Assistant Professor Dr. Wei Wei, Assistant Professor Dr. Sean Gibbons, Postdoctoral Fellow Dr. Samantha Piekos, and Hadlock – whose work directly relates to the immune system.

‘ISB Saved My Life’

ISB Foundation Board member Marne Anderson delivered a heartfelt appeal. She recalled taking part in an ISB program seven years ago that collected blood, microbiome, saliva and other data. Through close monitoring of her personalized data, Anderson was warned of extremely high cortisol levels, and was advised to see a doctor. This intervention allowed Anderson to catch a colon cancer diagnosis early. “Within three weeks, I had 10 inches of my colon removed, was on chemotherapy, and on the road to recovery. ISB saved my life,” she said. 

Earlier in the program, Heath emphasized the importance of clinical trial participants and the impact they’ve made during COVID-19. If you would like to explore clinical trial opportunities, you can find extensive information at clinicaltrials.gov.

Thanks to a generous $20,000 match from ISB board members, Reimagine: The Immune System was a fundraising success. To date, the evening generated $60,000 in unrestricted giving, and donations are still coming in. Heath underscored the importance of unrestricted gifts, saying ISB couldn’t study long COVID and other important areas without it. 

You can watch the Reimagine program in full here or by clicking play on the video above, and you can make a donation to help fuel ISB research here. 

Recent Articles

  • ISB President Dr. Jim Heath

    ISB Leading NCI Comprehensive Cancer Center to Study Sequential Targeted Inhibitors and Immunotherapies

    The NCI awarded ISB a 5-year, $13 million grant to lead a comprehensive cancer center and study sequential combinations of targeted inhibitors and immunotherapies. The program is designed to determine if the treatments yield greater patient benefit when administered in sequence rather than as monotherapies or as simultaneously administered combinations.

  • 2022 ISB Virtual Microbiome Series

    2022 ISB Virtual Microbiome Series Announced

    Our multi-day microbiome-themed virtual course and symposium is back for the third year! ISB is hosting a two-day course on October 12 & 13, 2022, followed by a symposium on October 14, 2022 on global perspectives in microbiome research. Both events are virtual and free. The intended audience for these events are graduate students, postdocs, principal investigators, industry scientists, educators, clinicians, or any other variety of microbiome-curious people from across the globe.

  • Bugs vs. Drugs: How Our Microbiomes Can Explain Our Response to Statins

    ISB Assistant Professor Dr. Sean Gibbons talked about the science behind statins in our most recent Research Roundtable virtual presentation. His talk was titled “Bugs vs. Drugs: How Our Unique Gut Microbiomes Shape Our Personalized Responses to Statins.”